United Services Automobile Association’s Acadia Pharmaceuticals ACAD Stock Holding History

United Services Automobile Association’s Portfolio ACAD Stock Details ACAD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-17,343	Closed	-$464K	–	438
2019 Q2	$464K	Hold	17,343	–	–	﹤0.01%	1654
2019 Q1	$466K	Sell	17,343 -2,034	-10%	-$47.5K	﹤0.01%	1660
2018 Q4	$313K	Buy	19,377 +4,114	+27%	+$79.9K	﹤0.01%	1792
2018 Q3	$317K	Hold	15,263	–	–	﹤0.01%	1910
2018 Q2	$233K	Hold	15,263	–	–	﹤0.01%	2060
2018 Q1	$343K	Buy	+15,263	New	+$423K	﹤0.01%	1844

Other funds holding ACAD

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

United Services Automobile Association's ACAD Position: Q3 2019 in Review

United Services Automobile Association sold out of Acadia Pharmaceuticals (ACAD) in Q3 2019, closing a stake of 17,343 shares — an estimated $464K sold.

United Services Automobile Association first reported a position in ACAD in Q1 2018 and held it in 6 quarters. The position peaked at $466K in Q1 2019. 231 funds tracked by Wall St. Rank hold ACAD as of Q3 2019.

United Services Automobile Association reported no remaining Acadia Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
United Services Automobile Association sold 17,343 Acadia Pharmaceuticals shares in Q3 2019, an estimated $464K.
United Services Automobile Association first reported a position in Acadia Pharmaceuticals in Q1 2018 and held it in 6 quarters.
United Services Automobile Association's Acadia Pharmaceuticals position peaked at $466K in Q1 2019.
231 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q3 2019.

Based on United Services Automobile Association's 13F filing for Q3 2019, filed 13 Nov 2019.